Interest Groups

House Rejects Experimental Drug Bill - Health Care and Life Sciences News

Get the news you want the way you want it: click the RSS button in the right corner to add this feed to your RSS reader, or click here to subscribe to this content. By subscribing, you’ll find this news on your Member Account page, and the latest articles will be emailed to you in your customized IndyBar E-Bulletin e-newsletter.

Health Care and Life Sciences News

Posted on: Mar 14, 2018

The House recently rejected an experimental drug “Right to Try” bill which would allow very ill patients to avoid standards of the FDA in order to use experimental treatments. Read more about the measure here.

This article was submitted by Allison Emhardt, Indiana University Health. If you would like to submit content or write an article for the Health Care & Life Sciences Section, please email Kara Sikorski at


Indianapolis Bar Association (IndyBar) est. 1878 | 4,536 Members (as of 2.11.21)